LEXARIA BIOSCIENCE CORP. Payments to Acquire Investments
LEXARIA BIOSCIENCE CORP. (LEXX) reported Payments to Acquire Investments of $70.00 thousand for the 12-month period ending 2018-08-31, per its 10-K filed 2019-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2019-11-14
- LEXARIA BIOSCIENCE CORP. payments to acquire investments for the quarter ending 2018-08-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. payments to acquire investments for the quarter ending 2018-05-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. payments to acquire investments for the quarter ending 2018-02-28 was $0.00.
- LEXARIA BIOSCIENCE CORP. payments to acquire investments for the quarter ending 2017-11-30 was $70.00K.
- LEXARIA BIOSCIENCE CORP. payments to acquire investments for fiscal 2018 was $70.00K.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2018-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 derived: sum of 3 quarters · filed 2019-11-14 | $70.00K 10-K · filed 2019-11-14 |
| 2018-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08 | $0.00 derived: sum of 2 quarters · filed 2019-07-08 | $70.00K 10-Q · filed 2019-07-08 | |
| 2018-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $70.00K 10-Q · filed 2019-04-15 | ||
| 2017-11-30 | $70.00K 10-Q · filed 2019-01-11 | |||
| 2017-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $0.00 derived: sum of 2 quarters · filed 2018-07-13 | $0.00 10-Q · filed 2018-07-13 | |
| 2017-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $0.00 10-Q · filed 2018-04-12 | ||
| 2016-11-30 | $0.00 10-Q · filed 2018-01-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |